Clinical trial
A Clinical Study Examining the Safety and Effectiveness of a New Medication…
NCT00203216 · Thomas Jefferson University, Other · Completed
Key facts
| NCT number | NCT00203216 |
|---|---|
| Title | A Clinical Study Examining the Safety and Effectiveness of a New Medication (Keppra®) for the Prevention of Migraine Headaches |
| Official title | A Single-Center, Open-Label Trial Examining the Efficacy and Safety of Levetiracetam for the Prophylactic Treatment of Migraine, With or Without Aura |
| Lead sponsor | Thomas Jefferson University, Other |
| Collaborators | UCB Pharma Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Migraine |
| Intervention type | Drug, Procedure |
| Interventions | levetiracetam, Transcranial Magnetic Stimulation |
| Enrollment | 31 |
| Start date | Sep 1, 2002 |
| Primary completion | Jan 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Sep 20, 2005 |
| Last update posted | Aug 11, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: